{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:45:35Z","timestamp":1769579135510,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1245\/s10434-014-3903-3","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T15:48:51Z","timestamp":1405957731000},"page":"3297-3303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Incremental Risk Associated with Contralateral Prophylactic Mastectomy and the Effect on Adjuvant Therapy"],"prefix":"10.1245","volume":"21","author":[{"given":"Dustin L.","family":"Eck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galen","family":"Perdikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupendra","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Bagaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"issue":"33","key":"3903_CR1","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","volume":"25","author":"TM Tuttle","year":"2007","unstructured":"Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203\u20135209.","journal-title":"J Clin Oncol."},{"key":"3903_CR2","doi-asserted-by":"crossref","unstructured":"Lostumbo L, Carbine N, Wallace J, Ezzo J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2004;(4):CD002748.","DOI":"10.1002\/14651858.CD002748.pub2"},{"issue":"19","key":"3903_CR3","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2005.10.080","volume":"23","author":"LJ Herrinton","year":"2005","unstructured":"Herrinton LJ, Barlow WE, Yu O, et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005;23(19):4275\u20134286.","journal-title":"J Clin Oncol."},{"issue":"10","key":"3903_CR4","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1245\/s10434-009-0547-9","volume":"16","author":"NB Jones","year":"2009","unstructured":"Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16(10):2691\u20132696.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"3903_CR5","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1245\/s10434-013-3108-1","volume":"20","author":"ME Miller","year":"2013","unstructured":"Miller ME, Czechura T, Martz B, et al. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Ann Surg Oncol. 2013;20(13):4113\u20134120.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"3903_CR6","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/cncr.20617","volume":"101","author":"K Goldflam","year":"2004","unstructured":"Goldflam K, Hunt KK, Gershenwald JE, et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004;101(9):1977-1986.","journal-title":"Cancer."},{"issue":"9","key":"3903_CR7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","volume":"27","author":"TM Tuttle","year":"2009","unstructured":"Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362\u20131367.","journal-title":"J Clin Oncol."},{"issue":"23","key":"3903_CR8","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1002\/cncr.24623","volume":"115","author":"CC McLaughlin","year":"2009","unstructured":"McLaughlin CC, Lillquist PP, Edge SB. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer. 2009;115(23):5404-5412.","journal-title":"Cancer."},{"issue":"11","key":"3903_CR9","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1245\/s10434-011-1914-x","volume":"18","author":"A Abbott","year":"2011","unstructured":"Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T. Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol. 2011;18(11):3129\u20133136.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"3903_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/djq018","volume":"102","author":"I Bedrosian","year":"2010","unstructured":"Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102(6):401\u2013409.","journal-title":"J Natl Cancer Inst."},{"issue":"7","key":"3903_CR11","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.1995.13.7.1578","volume":"13","author":"P Broet","year":"1995","unstructured":"Broet P, de la Rochefordiere A, Scholl SM, et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol. 1995;13(7):1578\u20131583.","journal-title":"J Clin Oncol."},{"issue":"8","key":"3903_CR12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1993.11.8.1545","volume":"11","author":"EA Healey","year":"1993","unstructured":"Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11(8):1545\u20131552.","journal-title":"J Clin Oncol."},{"key":"3903_CR13","doi-asserted-by":"crossref","unstructured":"Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010;(11):CD002748.","DOI":"10.1002\/14651858.CD002748.pub3"},{"issue":"6","key":"3903_CR14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9610(00)00505-5","volume":"180","author":"EA Peralta","year":"2000","unstructured":"Peralta EA, Ellenhorn JD, Wagman LD, Dagis A, Andersen JS, Chu DZ. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg. 2000;180(6):439\u2013445.","journal-title":"Am J Surg."},{"issue":"1","key":"3903_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11912-009-0070-y","volume":"12","author":"TM Tuttle","year":"2010","unstructured":"Tuttle TM, Abbott A, Arrington A, Rueth N. The increasing use of prophylactic mastectomy in the prevention of breast cancer. Curr Oncol Rep.2010;12(1):16\u201321.","journal-title":"Curr Oncol Rep."},{"issue":"6","key":"3903_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.7326\/0003-4819-159-6-201309170-00003","volume":"159","author":"SM Rosenberg","year":"2013","unstructured":"Rosenberg SM, Tracy MS, Meyer ME, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013;159(6):373\u2013381.","journal-title":"Ann Intern Med."},{"issue":"6","key":"3903_CR17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7326\/0003-4819-159-6-201309170-00011","volume":"159","author":"PR Portschy","year":"2013","unstructured":"Portschy PR, Tuttle TM. Contralateral prophylactic mastectomy: perceptions versus reality. Ann Intern Med. 2013;159(6):428\u2013429.","journal-title":"Ann Intern Med."},{"issue":"10","key":"3903_CR18","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1245\/s10434-013-3116-1","volume":"20","author":"F Osman","year":"2013","unstructured":"Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol. 2013;20(10):3212\u20133217.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"3903_CR19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2000.18.3.584","volume":"18","author":"M Colleoni","year":"2000","unstructured":"Colleoni M, Bonetti M, Coates AS, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol. 2000;18(3):584\u2013590.","journal-title":"J Clin Oncol."},{"key":"3903_CR20","doi-asserted-by":"crossref","unstructured":"Gagliato Dde M, Gonzalez-Angulo AM, Lei X, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol. 2014;32(8):735\u2013744.","DOI":"10.1200\/JCO.2013.49.7693"},{"issue":"20","key":"3903_CR21","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1200\/JCO.2003.01.073","volume":"21","author":"C Shannon","year":"2003","unstructured":"Shannon C, Ashley S, Smith IE. Does timing of adjuvant chemotherapy for early breast cancer influence survival? J Clin Oncol. 2003;21(20):3792\u20133797.","journal-title":"J Clin Oncol."},{"issue":"30","key":"3903_CR22","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1200\/JCO.2005.01.6089","volume":"24","author":"C Lohrisch","year":"2006","unstructured":"Lohrisch C, Paltiel C, Gelmon K, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2006;24(30):4888\u20134894.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3903-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-3903-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3903-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T01:42:40Z","timestamp":1565660560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-3903-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3903"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-3903-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]}}}